Stephen Hoge (President) sold ~$8.6M of Moderna
Planned saleWant the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MRNA · NASDAQ · Biotechnology
$195.00−4.33 (−2.17%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Moderna (MRNA) · oqro.io/stocks/MRNA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
240 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Stephen Hoge (President) sold ~$8.6M of Moderna
Planned saleStephen Hoge (President) sold ~$7.18M of Moderna
Planned saleStephen Hoge (President) sold ~$1.08M of Moderna
Planned saleStephen Hoge (President) sold ~$34K of Moderna
Planned saleHoge Stephen (Officer) plans to sell ~$8.3M of Moderna
Planned, from payHoge Stephen (Officer) plans to sell ~$8.6M of Moderna
Planned, from payStephen Hoge (President) sold ~$8.64M of Moderna
Planned saleStephen Hoge (President) sold ~$8.28M of Moderna
Planned saleStephen Hoge (President) sold ~$96K of Moderna
Planned saleHoge Stephen (Officer) plans to sell ~$8.64M of Moderna
Planned, from payHoge Stephen (Officer) plans to sell ~$8.37M of Moderna
Planned, from payStephen Hoge (President) sold ~$5.88M of Moderna
Planned saleStephen Hoge (President) sold ~$5.81M of Moderna
Planned saleHoge Stephen (Officer) plans to sell ~$5.88M of Moderna
Planned, from payJames M Mock (Chief Financial Officer) sold ~$2.67M of Moderna
Planned saleJames M Mock (Chief Financial Officer) sold ~$2.02M of Moderna
Planned saleHoge Stephen (Officer) plans to sell ~$5.81M of Moderna
Planned, from payJames M. Mock (Officer) plans to sell ~$4.69M of Moderna
Planned, from payShannon Thyme Klinger (Chief Legal Officer) sold ~$486K of Moderna
Planned saleStephane Bancel (Chief Executive Officer) sold ~$11M of Moderna
Planned saleStephane Bancel (Chief Executive Officer) sold ~$8.29M of Moderna
Planned saleStephane Bancel (Chief Executive Officer) sold ~$7.11M of Moderna
Planned saleStephane Bancel (Chief Executive Officer) sold ~$2.32M of Moderna
Planned saleStephen Hoge (President) sold ~$3.61M of Moderna
Planned saleStephen Hoge (President) sold ~$2.74M of Moderna
Planned saleShannon Thyme Klinger (Chief Legal Officer) sold ~$174K of Moderna
Planned saleInsider selling
Traded May 21 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +312.6% · S&P 500 −7.1% · to Nov 20
A Moderna director sold $434K of Moderna shares. The filing does not indicate a pre-arranged trading plan.
Stephen Hoge (President) sold ~$2.58M of Moderna
Planned saleAbbas Hussain (Director) sold ~$265K of Moderna
Planned saleShannon Thyme Klinger (Chief Legal Officer) sold ~$726K of Moderna
Planned saleStephen Hoge (President) sold ~$7.81M of Moderna
Planned saleInsider selling
Traded Dec 11, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade +558.1% · S&P 500 +0.1% · to Nov 20
A Moderna director sold $703K of Moderna shares. The filing does not indicate a pre-arranged trading plan.
Abbas Hussain (Director) sold ~$14K of Moderna
Planned saleAbbas Hussain (Director) sold ~$8.7K of Moderna
Planned saleTraded Mar 3, 2025 · largest single transaction ~$3.19M
Mar 3, 2025~$3.19M · 103K sh @ $31.04
DetailsOfficial recordInsider buying
Traded Mar 3, 2025 · filed 1 day later
Since the trade +544.2% · S&P 500 +18.2% · to Nov 20
A Moderna director paid $1M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month. Shares held went up 11% with this purchase.
Shannon Thyme Klinger (Chief Legal Officer) sold ~$24K of Moderna
Automatic saleStephen Hoge (President) sold ~$14K of Moderna
Automatic saleShannon Thyme Klinger (Chief Legal Officer) sold ~$4.8K of Moderna
Automatic saleMar 3, 2025~$1.81M · 57K sh @ $31.53
DetailsOfficial record0 open-market purchases and 24 open-market sales by insiders of MRNA between Jan 14, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 6, 2026. The data provider lists the next release for Feb 11, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 6, 2026 | 3 sales | None | 4 sales |
| Jul 31, 2026 | 1 sale | None | 4 sales |
| May 1, 2026 | None | 1 sale | 2 sales |
| Feb 13, 2026 | None | None | 2 sales |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies